Abingdon Health Ltd. announced the appointment of Dene Baldwin as Group Technical Director. Dene has a wealth of experience in the development, manufacture and commercialisation of immunodiagnostic assays and systems, particularly on-site and point of care systems. He was previously Group Technical Director at Alere Toxicology plc and prior to that held similar positions at Concateno plc and Cozart plc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11 GBX | -1.79% | 0.00% | 0.00% |
May. 15 | Abingdon pregnancy self-tests now available under the Boots brand | AN |
May. 15 | Abingdon Health Plans UK Launch of Saliva Pregnancy Test Product for Spring | MT |
1st Jan change | Capi. | |
---|---|---|
0.00% | 44.81M | |
-5.37% | 12.35B | |
-3.75% | 8.17B | |
+7.79% | 5.77B | |
+33.10% | 5.65B | |
-12.12% | 4.1B | |
+14.18% | 2.67B | |
-5.70% | 2.31B | |
+18.60% | 2.02B | |
-6.70% | 1.81B |
- Stock Market
- Equities
- ABDX Stock
- News Abingdon Health Plc
- Abingdon Appoints Dene Baldwin as New Group Technical Director